These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2637701)

  • 1. Effect of misoprostol on fat malabsorption in cystic fibrosis.
    Littlewood JM; Kelleher J
    Arch Dis Child; 1989 Jul; 64(7):1096-7. PubMed ID: 2637701
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of misoprostol on fat malabsorption in cystic fibrosis.
    Robinson PJ; Sly PD; Smith AL
    Arch Dis Child; 1988 Sep; 63(9):1081-2. PubMed ID: 3140739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fat malabsorption in cystic fibrosis patients.
    Murphy J; Laiho K; Wootton S
    Am J Clin Nutr; 1999 Nov; 70(5):943-6. PubMed ID: 10539762
    [No Abstract]   [Full Text] [Related]  

  • 4. High dose pancreatic enzymes in cystic fibrosis.
    Robinson PJ; Sly PD
    Arch Dis Child; 1990 Mar; 65(3):311-2. PubMed ID: 2334211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile salt kinetics in cystic fibrosis: influence of pancreatic enzyme replacement.
    Watkins JB; Tercyak AM; Szczepanik P; Klein PD
    Gastroenterology; 1977 Nov; 73(5):1023-8. PubMed ID: 332576
    [No Abstract]   [Full Text] [Related]  

  • 6. Fat malabsorption in cystic fibrosis patients receiving enzyme replacement therapy is due to impaired intestinal uptake of long-chain fatty acids.
    Kalivianakis M; Minich DM; Bijleveld CM; van Aalderen WM; Stellaard F; Laseur M; Vonk RJ; Verkade HJ
    Am J Clin Nutr; 1999 Jan; 69(1):127-34. PubMed ID: 9925134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of four pancreatic extracts in cystic fibrosis.
    Beverley DW; Kelleher J; MacDonald A; Littlewood JM; Robinson T; Walters MP
    Arch Dis Child; 1987 Jun; 62(6):564-8. PubMed ID: 3304172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current concepts: pancreatic extracts.
    Littman A; Hanscom DH
    N Engl J Med; 1969 Jul; 281(4):201-4. PubMed ID: 4892805
    [No Abstract]   [Full Text] [Related]  

  • 9. [Serum nephelometry arter oral fat overload. A contribution to the diagnosis of fat absorption disorders in childhood].
    Richter F; Toussaint W
    Monatsschr Kinderheilkd (1902); 1969 Jun; 117(6):460-2. PubMed ID: 5376090
    [No Abstract]   [Full Text] [Related]  

  • 10. Faecal bile acid and dietary residue excretion in cystic fibrosis: age group variations.
    Walters MP; Littlewood JM
    J Pediatr Gastroenterol Nutr; 1998 Sep; 27(3):296-300. PubMed ID: 9740200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cimetidine as an adjunct to oral enzymes in the treatment of malabsorption due to cystic fibrosis.
    de Biéville F; Neijens HJ; Fernandes J; van Caillie M; Kerrebijn KF
    Acta Paediatr Scand; 1981 Jan; 70(1):33-7. PubMed ID: 6908433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal fat and nitrogen in healthy children and in children with malabsorption or maldigestion.
    Shmerling DH; Forrer JC; Prader A
    Pediatrics; 1970 Nov; 46(5):690-5. PubMed ID: 5481070
    [No Abstract]   [Full Text] [Related]  

  • 13. Fat malabsorption in cystic fibrosis: comparison of quantitative fat assay and a novel assay using fecal lauric/behenic acid.
    Dorsey J; Buckley D; Summer S; Jandacek RJ; Rider T; Tso P; Narkewicz MR; Heubi JE
    J Pediatr Gastroenterol Nutr; 2010 Apr; 50(4):441-6. PubMed ID: 20179641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of two pancreatin microsphere preparations in cystic fibrosis.
    Elliott RB; Escobar LC; Lees HR; Akroyd RM; Reilly HC
    N Z Med J; 1992 Mar; 105(930):107-8. PubMed ID: 1553114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steatorrhea and azotorrhea and their relation to growth and nutrition in adolescents and young adults with cystic fibrosis.
    Lapey A; Kattwinkel J; Di Sant'Agnese PA; Laster L
    J Pediatr; 1974 Mar; 84(3):328-34. PubMed ID: 4811984
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of taurine supplementation on fat and energy absorption in cystic fibrosis.
    De Curtis M; Santamaria F; Ercolini P; Vittoria L; De Ritis G; Garofalo V; Ciccimarra F
    Arch Dis Child; 1992 Sep; 67(9):1082-5. PubMed ID: 1417050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fat balance in cystic fibrosis: is it only a simple matter of maldigestion and malabsorption?
    Uomo G
    JOP; 2004 Mar; 5(2):109-10. PubMed ID: 15007195
    [No Abstract]   [Full Text] [Related]  

  • 18. Monitoring pancreatin supplementation in cystic fibrosis patients with the 13C-Hiolein breath test: evidence for normalized fat assimilation with high dose pancreatin therapy.
    Braden B; Picard H; Caspary WF; Posselt HG; Lembcke B
    Z Gastroenterol; 1997 Feb; 35(2):123-9. PubMed ID: 9066102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved residual fat malabsorption and growth in children with cystic fibrosis treated with a novel oral structured lipid supplement: A randomized controlled trial.
    Stallings VA; Tindall AM; Mascarenhas MR; Maqbool A; Schall JI
    PLoS One; 2020; 15(5):e0232685. PubMed ID: 32384122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of fat absorption in cystic fibrosis patients and controls by a rapid micro procedure: a comparison with fecal fat excretion method.
    Kutty KM; Bridger H; Vaze D; Davis AJ
    Clin Biochem; 1983 Oct; 16(5):303-5. PubMed ID: 6652887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.